WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20

WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021

Published:2022-01-31 Issue:1 Volume:11 Page:384-391
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Liu Margaret A.¹,Zhou Tiequn²,Sheets Rebecca L.³,Meyer Heidi⁴,Knezevic Ivana²

Affiliation:

1. ProTherImmune, Lafayette, CA, USA

2. Department of Health Product Policy and Standards, World Health Organization, Geneva, Switzerland

3. Independent Expert, Silver Spring, MD, USA

4. Paul-Ehrlich-Institut, Langen, Germany

Funder

Center for Biologics Evaluation and Research

US Food and Drug Administration

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2026742

Reference11 articles.

1. World Health Organization. Main outcomes of the meeting of the WHO Expert Committee on Biological Standardization held from 24 to 28 August 2020. Geneva; 2020. [cited 2021 Jul 23] Available from: https://www.who.int/publications/m/item/WHO-ECBS-aug-2020-executive_summary.

2. World Health Organization. Main outcomes of the meeting of the WHO Expert Committee on Biological Standardization held on 9 and 10 December 2020. Geneva; 2020. [cited 2021 Jul 23] Available from: https://www.who.int/publications/m/item/ECBS-Executive-Summary.IF.IK.TW-15_Dec_2020.

3. World Health Organization. Prioritizing diseases for research and development in emergency contexts[website] Geneva. [cited 2021 Aug 23] Available from: https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts, accessed 3 August 2021.

4. World Health Organization. Biologicals [website]. Geneva. [cited 2021 Jul 22] Available from: https://www.who.int/health-topics/biologicals#tab=tab_1.

5. Development of mRNA Vaccines: Scientific and Regulatory Issues

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends;Biomarker Research;2024-08-31

2. Introduction to RNA Vaccines Post COVID-19;Methods in Molecular Biology;2024

3. Challenges Faced by States and the WHO in Efficiently Regulating the Use of mRNA Vaccines;IECV 2023;2023-12-01

4. Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity;SLAS Technology;2023-10

5. Availability and use of Standards in vaccine development;npj Vaccines;2023-06-30